A Drosophila model for mechanistic investigation of tau protein spread.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 Sep 2024
Historique:
received: 22 04 2024
accepted: 09 08 2024
medline: 1 10 2024
pubmed: 1 10 2024
entrez: 1 10 2024
Statut: ppublish

Résumé

Brain protein aggregates are a hallmark of neurodegenerative disease. Previous work indicates that specific protein components of these aggregates are toxic, including tau (encoded by MAPT) in Alzheimer's disease and related tauopathies. Increasing evidence also indicates that these toxic proteins traffic between cells in a prion-like fashion, thereby spreading pathology from one brain region to another. However, the mechanisms involved in trafficking are poorly understood. We therefore developed a transgenic Drosophila model to facilitate rapid evaluation of candidate tau trafficking modifiers. Our model uses the bipartite Q system to drive co-expression of tau and GFP in the fly eye. We found age-dependent spread of tau into the brain, represented by detection of tau, but not of GFP. We also found that tau trafficking was attenuated upon inhibition of the endocytic factor dynamin (encoded by shi) or knockdown of glycogen synthase kinase-3β (GSK-3β, encoded by sgg). Further work revealed that dynamin promoted tau uptake in recipient tissues, whereas GSK-3β appeared to promote tau spread via direct phosphorylation of tau. Our robust and flexible system will promote the identification of tau-trafficking components involved in the pathogenesis of neurodegenerative diseases.

Identifiants

pubmed: 39350752
pii: 362225
doi: 10.1242/dmm.050858
pii:
doi:

Substances chimiques

tau Proteins 0
Drosophila Proteins 0
Glycogen Synthase Kinase 3 beta EC 2.7.11.1
Dynamins EC 3.6.5.5
Glycogen Synthase Kinase 3 EC 2.7.11.26
Sgg protein, Drosophila EC 2.7.11.1
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : R21AG070374
Pays : United States
Organisme : University of Washington

Informations de copyright

© 2024. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Auteurs

Kondalarao Bankapalli (K)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Ruth E Thomas (RE)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Evelyn S Vincow (ES)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Gillian Milstein (G)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Laura V Fisher (LV)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Leo J Pallanck (LJ)

Department of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH